Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in NVCR — NovoCure Ltd

CIK 1323645 PARIS, I0

Position in NVCR

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$1,520,866
+$599,139 QoQ
Shares Held
139,529
+95.7% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Dec 31, 2024
CallValue
$524,480
CallShares
17,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

CAPITAL FUND MANAGEMENT S.A. holds $222,994,073 across 14 Medical Devices names. NVCR ranks #10 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,520,866 139,529
2025-12-31 $921,727 71,286
2025-09-30 $578,454 44,772
2024-12-31 $524,480 17,600
2024-09-30 $435,451 27,860
2024-09-30 $275,088 17,600
2024-06-30 $529,317 30,900
2024-06-30 $1,724,802 100,689
2024-03-31 $367,305 23,500
2024-03-31 $1,589,571 101,700
2024-03-31 $1,109,245 70,969
2023-12-31 $804,891 53,911
2023-12-31 $2,478,380 166,000
2023-12-31 $740,528 49,600
2023-09-30 $1,863,403 115,381
2023-09-30 $308,465 19,100
2023-03-31 $852,484 14,175
2021-12-31 $1,313,900 17,500
2021-09-30 $2,114,294 18,200
2020-12-31 $2,249,520 13,000
2020-12-31 $4,290,699 24,796
2020-03-31 $1,629,695 24,201